Medicine Description torisel 30mg
Torisel is a targeted anticancer medication used in the treatment of certain advanced malignancies. It works by
inhibiting the growth and proliferation of cancer cells while preventing their spread throughout the body. The drug
plays an important role in improving clinical outcomes for patients with advanced renal cell carcinoma.
Torisel exerts its therapeutic effect by selectively inhibiting proteins involved in cancer cell growth, division, and
the formation of blood vessels that supply tumors with nutrients. This targeted mechanism helps slow disease
progression and improve disease control. The medication should be administered only in hospitals or specialized
oncology centers under the supervision of a qualified oncologist.
Torisel Ingredients
Torisel Strength
Uses of Torisel
Treatment of advanced renal cell carcinoma.
Targeted anticancer therapy to inhibit tumor cell growth and proliferation.
Treatment of mantle cell lymphoma in selected patients.
Torisel Dosage
The dosage depends on the patient's clinical condition and response to treatment. The usual recommended dose is 25 mg
administered by intravenous infusion once weekly, or according to the treatment protocol prescribed by the oncologist.
The physician may reduce the dose or temporarily delay treatment depending on the patient's response or the occurrence
of significant adverse effects. Torisel is administered as a slow intravenous infusion over 30 to 60 minutes,
following the approved administration procedures within the healthcare facility.
Premedication with antihistamines or other preventive medications may be prescribed before each infusion to reduce the
risk of infusion-related hypersensitivity reactions, depending on the patient's clinical condition.
Torisel Side Effects
General fatigue, weakness, and tiredness during treatment.
Mouth ulcers or inflammation of the mucous membranes of the gastrointestinal tract.
Skin rash, dry skin, or itching.
Temporary elevation of blood glucose, triglyceride, and cholesterol levels.
-
Decreased red blood cells, white blood cells, and platelet counts, increasing the risk of infection and bleeding.
Contraindications of Torisel
This medication is contraindicated in patients with known hypersensitivity to temsirolimus, sirolimus, or any of the
inactive ingredients in the formulation. It should also be avoided in patients with severe hepatic impairment or those
with significant renal dysfunction unless careful medical monitoring is available.
Treatment should not be initiated in patients with active, uncontrolled infections or in those who have recently
undergone major surgery because of the increased risk of delayed wound healing and bleeding complications.
Torisel Alternatives
How to Use Torisel Correctly
The medication must be prepared and diluted by qualified healthcare professionals according to the approved
prescribing information while maintaining strict aseptic technique within the hospital or oncology treatment center.
Torisel should not be mixed with other intravenous medications or infusion solutions unless compatibility has been
confirmed according to the manufacturer's recommendations. During the infusion, the patient's vital signs and overall
clinical condition should be monitored continuously so that any infusion-related reactions or adverse events can be
identified and managed promptly.
Unless medically contraindicated, patients are also encouraged to maintain adequate hydration by drinking sufficient
fluids to help support kidney function throughout the course of treatment.
Storage Conditions
Store the vial in a refrigerator at 2°C to 8°C.
Do not freeze or expose the medication to excessive heat.
Keep the vial in its original carton to protect it from light.
Store out of the reach of children.